Quick Menu

Upcoming Journals

British Microbiology Research Journal

British Microbiology Research Journal, ISSN: 2231-0886,Vol.: 2, Issue.: 2 (April-June)

Original Research Article

First Report of Multidrug-Resistant ESBL-Producing Urinary Escherichia coli in Jordan

 

L. F. Nimri1* and B. A. Azaizeh1

1Department of Medical Laboratory Sciences, Jordan University of Science & Technology, Irbid 22110, Jordan.

 

Abstracts

 

Aims: To detect ESBL-producing E. coli isolates and the genes underlying their resistance to β-lactams and sulfamethoxazole.
Place and Duration of Study: Department of Medical Laboratory Sciences, Jordan University of Science & Technology, Irbid 22110, Jordan, between January 2009 and December 2010.
Methodology: The blaCTX-M, blaTEM, blaSHV genes and sul genes were tested for in 165 urinary E. coli isolates by PCR assays. The association between the presence of gene and the antibiotic resistant was analyzed.
Results: Multidrug resistance was detected among the isolates. Eighty-three (50.3%) of the isolates were ESBL-producing, 67(80.7%) had either blaCTX-M or blaTEM, or both and none had blaSHV gene, sul2 (41.2%) was prevalent (21.8%) isolates had two sul genes, while (1.8%) isolates had three sul genes. A significant association (p ≤ 0.05) was found between blaCTX-M, or blaTEM and resistance to several antibiotics e.g., cefixime. Several (29.9%) of the ESBL-producing strains harbored multiple ESBL genes and had high resistance to various antibiotic classes.
Conclusion: The results revealed a high-level of sul2 and blaCTX-M positive ESBL isolates among other β-lactam resistant genes circulating in the community. These findings indicate that these patients are more likely to have ineffective initial empirical antimicrobial therapy.

 

Keywords :

Extended-spectrum β-lactamase; multidrug resistance; urinary Escherichia coli; bla/sul genes.

 

Full Article - PDF    Page 71-81    Article Metrics

 

DOI : 10.9734/BMRJ/2012/1360

Review History    Comments

Search this site

Advanced Search

Announcement & News

Nature (Impact Factor: 41.6) confirmed high standard of SDI journal and its editors

We are happy to inform that Nature (Impact Factor: 41.6) confirmed high standard of SDI journal and ...

ISI Thomson Reuters selected British Journal of Pharmaceutical Research for Emerging Sources Citation Index

We are delighted to inform that ISI Thomson Reuters selected British Journal of Pharmaceutical Resea...

SCOPUS selected Annual Research & Review in Biology (ARRB)

We are delighted to inform that famous indexing organization SCOPUS (from Elsevier) selected  A...

Index Copernicus Evaluation Result Released

We are delighted to inform that Index Copernicus (a leading indexing organization from Pol...

Journal Repository (JR): Permanent Digital Archiving of SDI journals

SDI is happy to announce that all our journals are now permanently archived in Journal Repository (J...

SDI journal got 35th ranking in Publons

We are delighted to announce (as of 04/01/2016) that British Journal of Medicine and Medical Re...

Growth of SDI and world publication market

As of 2014, total 25,064 journals are competing in World market of journal publication. In 2011, tot...

Science (IF: 31) report confirmed the high standard of SDI journal

As per a recent report (Link) of Science journal (present Impact factor 31), one of our journal (Bri...

SDI introduced Post-publication peer review by its comment section

SDI journals encourage Post-publication peer review by its comment section   Policy details a...

SDI promotes transparent Advanced OPEN peer review

We have migrated to transparent and toughest ‘Advanced OPEN peer review’ system (...



SCIENCEDOMAIN Awards

  • No Awards listed.

Browser Compatibility : Mozila firefox, Google Crome and IE 7 & above. Creative Commons License Terms & Condition   |   Privacy Policy   |   Join Us   |   Help   |   Contact Us
© Copyright 2010-2018, SCIENCEDOMAIN international. All rights reserved.